Patent Assignment
Reel/Frame 039858/0967
Security Interest
Recorded: 2016-09-26
Pages: 19
Assignee
MIDCAP FINANCIAL TRUST, AS AGENT
7255 WOODMONT AVENUE, SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties
(39)
Compositions and Uses of Amidine Derivatives
PCT:
PCT/US2015/046578 ↗
Method for Producing Amidine Derivatives
PCT:
PCT/US2015/046582 ↗
Compositions Comprising a Plasma Kallikrein Inhibitor
PCT:
PCT/US2016/048456 ↗
Substituted Cyclopentane Compounds Useful as Neuraminidase Inhibitors
Patent:
6,410,594 →
Application:
09/202,351 →
Pyrrolidin-2-One Compounds and Their Use as Neuraminidase Inhibitors
Patent:
6,509,359 →
Application:
09/527,189 →
Substituted Cyclopentane and Cyclopentene Compounds Useful as Neuraminidase Inhibitors
Patent:
6,562,861 →
Application:
09/555,131 →
Novel Compounds Useful in the Complement, Coagulat and Kallikrein Pathways and Method for Their Preparation
Patent:
6,653,340 →
Application:
09/647,154 →
Substituted Pyrrolidine Compounds Useful as Neuraminidase Inhibitors
Patent:
6,518,299 →
Application:
09/692,518 →
Cyclopentane and Cyclopentene Compounds and Use for Detecting Influenza Virus
Patent:
6,503,745 →
Application:
09/831,140 →
Deazaguanine Analog, Preparation Thereof and Use Thereof
Patent:
6,458,799 →
Application:
09/847,998 →
Process for Preparing Substituted Cyclopentane Derivatives and Novel Crystalline Structures Thereof
Inhibiting T-Cell Proliferation
Preparation of Substituted Cyclopentane and Cyclopentene Compounds and Certain Intermediates
Patent:
6,762,316 →
Application:
10/019,217 →
Process for Preparing (-)-(1S, 4R) N-Protected 4-Amino-2-Cyclopentene-1-Carboxylate Esters
Inhibiting T-Cell Proliferation
Patent:
6,656,915 →
Application:
10/088,213 →
Biaryl Compounds as Serine Protease Inhibitors
Patent:
6,699,994 →
Application:
10/127,460 →
Preparation of Deazaguanine Analog
Patent:
6,780,993 →
Application:
10/367,950 →
Carboxy Pyrrole, Process of Preparing and Use as Precursor
Biaryl Compounds as Serine Protease Inhibitors
Process for the Preparation of 9-Deazaguanine Derivatives
Aza Nucleosides, Preparation Thereof and Use as Inhibitors of Rna Viral Polymerases
Process for the Preparation of Substituted Pyrrolidine Derivatives and Intermediates
Nucleosides, Preparation Thereof and Use as Inhibitors of Rna Viral Polymerases
Therapeutic Furopyrimidines and Thienopyrimidines
Hepatitis C Therapies
Methods for the Preparation of 9-Deazapurine Derivatives
Hepatitis C Therapies
Antiviral Nucleoside Analogs
Tetrahydrofuro [3,4-D] Dioxolane Compounds for Use in the Treatment of Viral Infections and Cancer
Antiviral Treatments
Useful Pharmaceutical Salts of 7- [(3R, 4R) - 3 - Hydroxy -4 - Hydroxymethyl - Pyrrolidin -1- Ylmethyl] -3, 5-Dihydro-Pyrrolo [3, 2-D] Pyrimidin -4-One
Methods and Compositions for Inhibition of Polymerase
Application:
13/879,110 →
Publication:
US 2013/0331404
Methods of Treating Hematologic Cancers
Application:
14/190,987 →
Publication:
US 2014/0178372
Antiviral Treatments
Compositions and Methods for Inhibiting Viral Polymerase
Antiviral Azasugar-Containing Nucleosides
Application:
14/441,762 →
Publication:
US 2015/0291596
Methods and Compositions for Inhibition of Polymerase
Anti-Influenza Compositions and Methods
Human Plasma Kallikrein Inhibitors
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 9, 1999
From: BABU, YARLAGADDA S.; CHAND, POORAN; MONTGOMERY, JOHN A.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 010080/0469 →
Assignment of Assignor's Interest
May 25, 2000
From: BABU, YARLAGADDA S.; CHAND, POORAN; MONTGOMERY, JOHN A.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 010876/0690 →
Assignment of Assignor's Interest
Sep 27, 2000
From: BABU, YARLAGADDA S.; BENNETT, J. CLAUDE; NIWAS, SHRI; ROWLAND, R. SCOTT
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 011166/0013 →
Assignment of Assignor's Interest
Aug 13, 2001
From: CHAND, POORAN; BABU, YARLAGADDA S.; BANTIA, SHANTA
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 012123/0074 →
Assignment of Assignor's Interest
Aug 27, 2001
From: MONTGOMERY, JOHN A.; MORRIS, PHILIP E. JR.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 012122/0623 →
Assignment of Assignor's Interest
Jan 15, 2002
From: BANTIA, SHANTA; MONTGOMERY, JOHN A.; MORRIS, PHILIP E., JR.
To: BIOCRYST PHARMACEUTICALS INC.
Reel/Frame 012498/0885 →
Assignment of Assignor's Interest
May 13, 2002
From: CHAND, POORAN; ELLIOTT, ARTHUR J.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 012966/0957 →
Assignment of Assignor's Interest
Jul 23, 2002
From: BABU, YARLAGADDA S.; ROWLAND, R. SCOTT; CHAND, POORAN; KOTIAN, PRAVIN L.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 013125/0597 →
Assignment of Assignor's Interest
Jul 30, 2002
From: BANTIA, SHANTA; MONTGOMERY, JOHN A.; OMURA, GEORGE A.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 013234/0581 →
Assignment of Assignor's Interest
Feb 19, 2003
From: KAMATH, VIVEKANAND; MORRIS, PHILIP E. JR
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 013777/0435 →
Assignment of Assignor's Interest
Apr 23, 2003
From: WINSLOW, CHRISTOPHER D.; MORRIS, PHILIP E., JR.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 013993/0246 →
Assignment of Assignor's Interest
Feb 15, 2006
From: BABU, YARLAGADDA S.; CHAND, POORAN; EL-KATTAN, YAHYA; WU, MINWAN
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 017261/0204 →
Assignment of Assignor's Interest
Feb 24, 2006
From: CHAND, POORAN; EL-KATTAN, YAHYA; KOTIAN, PRAVIN L.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 017304/0975 →
Assignment of Assignor's Interest
May 29, 2008
From: BABU, YARLAGADDA S.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 021014/0341 →
Assignment of Assignor's Interest
May 29, 2008
From: ATIGADDA, VENKATRAM R.; BROUILLETE, WAYNE J.; LUO, MING
To: THE UAB RESEARCH FOUNDATION
Reel/Frame 021014/0246 →
Assignment of Assignor's Interest
Feb 19, 2009
From: BABU, YARLAGADDA S.; CHAND, POORAN; EL-KATTAN, YAHYA; GHOSH, AJIT K.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 022283/0963 →
Release of Security Interest
Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
Security Interest
Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
Release of Security Interest
Apr 6, 2023
From: MIDCAP FINANCIAL TRUST
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 063348/0762 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
Security Interest
Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →